NCT06254131View on ClinicalTrials.gov

Preoperative Ondansetron Lozenge for Prevention of Postoperative Nausea and Vomiting in Caesarean Section

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

February 10, 2024

Primary Completion Date

October 5, 2024

Study Completion Date

October 5, 2024

Conditions
Ondansetron LozengePostoperative Nausea and VomitingCaesarean Section
Interventions
DRUG

Ondansetron lozenge (Ondalenz ©)

Patients will receive ondansetron lozenge 4 mg (Ondalenz ©), 2 hours before surgery.

DRUG

Ondansetron IV

Patients will receive 4 mg of ondansetron IV approximately 30 minutes before the end of surgery.

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06254131 - Preoperative Ondansetron Lozenge for Prevention of Postoperative Nausea and Vomiting in Caesarean Section | Biotech Hunter | Biotech Hunter